Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,291 | 791 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,142 | 247 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,344 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $947.04 | 68 | $0 (2024) |
| Amgen Inc. | $805.82 | 67 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $785.68 | 44 | $0 (2022) |
| PFIZER INC. | $730.81 | 63 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $684.30 | 46 | $0 (2024) |
| Lilly USA, LLC | $593.95 | 42 | $0 (2024) |
| ABBVIE INC. | $403.02 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $369.61 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,421 | 81 | Novo Nordisk Inc ($428.97) |
| 2023 | $1,589 | 103 | Novo Nordisk Inc ($509.35) |
| 2022 | $1,668 | 111 | Novo Nordisk Inc ($318.62) |
| 2021 | $1,492 | 90 | Novo Nordisk Inc ($588.42) |
| 2020 | $914.56 | 59 | Janssen Pharmaceuticals, Inc ($147.08) |
| 2019 | $1,593 | 126 | Novo Nordisk Inc ($347.06) |
| 2018 | $1,436 | 123 | Novo Nordisk Inc ($434.29) |
| 2017 | $1,177 | 98 | Novo Nordisk Inc ($383.66) |
All Payment Transactions
791 individual payment records from CMS Open Payments — Page 2 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: DIABETES | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Inflammation | ||||||
| 08/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Obesity | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Respiratory | ||||||
| 07/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Obesity | ||||||
| 07/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Obesity | ||||||
| 06/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Obesity | ||||||
| 05/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Inflammation | ||||||
| 04/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,536 | 3,920 | $291,760 | $103,533 |
| 2022 | 33 | 2,328 | 3,665 | $253,805 | $88,713 |
| 2021 | 30 | 1,938 | 2,974 | $214,353 | $79,202 |
| 2020 | 23 | 1,371 | 2,195 | $157,052 | $50,392 |
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 313 | $61,661 | $21,625 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 330 | $43,890 | $18,413 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 102 | 102 | $24,197 | $12,226 | 50.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 133 | 133 | $38,836 | $9,500 | 24.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 60 | 60 | $8,400 | $4,316 | 51.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 27 | 27 | $7,020 | $4,143 | 59.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,392 | $3,923 | 89.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 213 | 381 | $8,001 | $3,164 | 39.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 192 | 289 | $10,982 | $2,956 | 26.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 172 | 212 | $12,084 | $2,760 | 22.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 206 | 326 | $11,410 | $2,450 | 21.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 136 | 136 | $6,256 | $2,301 | 36.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $2,304 | $1,820 | 79.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $3,872 | $1,809 | 46.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 97 | 97 | $7,663 | $1,641 | 21.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 74 | 171 | $7,182 | $1,582 | 22.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 22 | 48 | $2,880 | $1,350 | 46.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 91 | 134 | $5,762 | $1,261 | 21.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 65 | 73 | $5,329 | $1,202 | 22.5% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 129 | 163 | $4,890 | $1,040 | 21.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 22 | $1,738 | $810.08 | 46.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $792.00 | $625.68 | 79.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 23 | 30 | $2,730 | $616.91 | 22.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 28 | 28 | $2,576 | $529.76 | 20.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 115 | 149 | $2,682 | $463.39 | 17.3% |
About Dr. William Stone, M.D
Dr. William Stone, M.D is a Family Medicine healthcare provider based in Union City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548240856.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Stone, M.D has received a total of $11,291 in payments from pharmaceutical and medical device companies, with $1,421 received in 2024. These payments were reported across 791 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($11,291).
As a Medicare-enrolled provider, Stone has provided services to 8,173 Medicare beneficiaries, totaling 12,754 services with total Medicare billing of $321,840. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Union City, TN
- Active Since 01/20/2006
- Last Updated 10/25/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1548240856
Products in Payments
- Ozempic (Drug) $794.09
- FARXIGA (Drug) $783.68
- XARELTO (Drug) $758.90
- TRADJENTA (Drug) $535.51
- TRINTELLIX (Drug) $505.00
- Saxenda (Drug) $502.04
- Rybelsus (Drug) $417.83
- Wegovy (Drug) $394.26
- JARDIANCE (Drug) $391.98
- Victoza (Drug) $361.08
- BREZTRI (Drug) $356.33
- Otezla (Drug) $325.04
- RYBELSUS (Drug) $284.15
- MOUNJARO (Drug) $277.70
- Tresiba (Drug) $275.43
- CHANTIX (Drug) $245.16
- JANUVIA (Drug) $227.41
- TRULICITY (Drug) $213.94
- EVENITY (Biological) $203.30
- LYRICA (Drug) $201.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Union City
Dr. Jerry Jurado, M.d, M.D
Family Medicine — Payments: $63,292
Francisco Gonzalez, Md, MD
Family Medicine — Payments: $14,250
John Clendenin, M.d, M.D
Family Medicine — Payments: $11,619
John Hale, M.d, M.D
Family Medicine — Payments: $11,378
Maria Paschalidis, D.o, D.O
Family Medicine — Payments: $10,936
Dr. Rogelio Allanigue, M.d, M.D
Family Medicine — Payments: $9,223